Fig. 11From: circCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP/RON axis in trophoblastsReceiver operating characteristic curve analysis. As a single predictor, MSP or circCRAMP1L showed low efficiency. When MSP was utilised in combination with circCRAMP1L, the predictive performance increased [AUC = 0.928 (95%CI 0.882–0.974)], with 80.0% sensitivity and 80.0% specificityBack to article page